Tekla Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-41,577	Closed	-$1.08M	–	206
2020 Q4	$1.08M	Hold	41,577	–	–	0.04%	176
2020 Q3	$1.54M	Hold	41,577	–	–	0.06%	165
2020 Q2	$2.13M	Hold	41,577	–	–	0.08%	156
2020 Q1	$1.31M	Sell	41,577 -171,985	-81%	-$9.08M	0.06%	159
2019 Q4	$12.7M	Hold	213,562	–	–	0.48%	45
2019 Q3	$7.83M	Buy	213,562 +28,955	+16%	+$1.15M	0.34%	59
2019 Q2	$8.59M	Hold	184,607	–	–	0.35%	64
2019 Q1	$7.41M	Buy	184,607 +42,318	+30%	+$1.9M	0.3%	70
2018 Q4	$6.54M	Sell	142,289 -46,998	-25%	-$2.26M	0.28%	72
2018 Q3	$8.4M	Hold	189,287	–	–	0.3%	73
2018 Q2	$7.42M	Hold	189,287	–	–	0.28%	78
2018 Q1	$13.7M	Buy	+189,287	New	+$13.9M	0.53%	43
2017 Q1	–	Sell	-102,800	Closed	-$1.29M	–	142
2016 Q4	$1.29M	Hold	102,800	–	–	0.05%	123
2016 Q3	$1.42M	Hold	102,800	–	–	0.05%	127
2016 Q2	$1.02M	Hold	102,800	–	–	0.04%	146
2016 Q1	$1.74M	Hold	102,800	–	–	0.07%	125
2015 Q4	$2.29M	Hold	102,800	–	–	0.08%	117
2015 Q3	$2.42M	Sell	102,800 -45,200	-31%	-$2.84M	0.09%	137
2015 Q2	$12.1M	Buy	+148,000	New	+$14.5M	0.44%	48

Other funds holding ESPR